DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis (Q33529158)

27 July 2017

DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis (English)

1 reference

27 July 2017

0 references

1 reference

1 reference

Felix Sedlmayer

7

0 references

author name string

Petra Feyer

1

1 reference

27 July 2017

Marie-Luise Sautter-Bihl

2

1 reference

27 July 2017

Wilfried Budach

3

1 reference

27 July 2017

Jürgen Dunst

4

1 reference

27 July 2017

Wulf Haase

5

1 reference

27 July 2017

Wolfgang Harms

6

1 reference

27 July 2017

Rainer Souchon

8

1 reference

27 July 2017

Frederik Wenz

9

1 reference

27 July 2017

Rolf Sauer

10

1 reference

27 July 2017

Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO)

11

1 reference

27 July 2017

26 January 2010

1 reference

Strahlentherapie und Onkologie

27 July 2017

1 reference

27 July 2017

186

1 reference

27 July 2017

2

1 reference

27 July 2017

63-69

1 reference

https://scigraph.springernature.com/pub.10.1007/s00066-010-2100-y

27 July 2017

0 references

cites work

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Carcinomatous meningitis appearing as acoustic neuromas: two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

21 January 2018

Neoplastic Meningitis

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Neoplastic meningitis-related prognostic significance of the Karnofsky performance status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Standard and novel radiotherapeutic approaches to neoplastic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Radiation-induced dementia in patients cured of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Leptomeningeal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

A phase I/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Leptomeningeal metastasis: survival and prognostic factors in 155 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

21 January 2018

Neoplastic meningitis

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Management of single brain metastasis: a practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

A randomized trial of surgery in the treatment of single metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: results of a matched pair analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Primary breast cancer phenotypes associated with propensity for central nervous system metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

The role of chemotherapy in the treatment of patients with brain metastases from solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

Analysis of outcome in patients reirradiated for brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2100-Y

The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study

21 January 2018

1 reference

12 December 2020

Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen

1 reference

12 December 2020

Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis

1 reference

12 December 2020

Leptomeningeal metastasis

1 reference

12 December 2020

Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients

1 reference

12 December 2020

A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases

1 reference

12 December 2020

High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

1 reference

12 December 2020

The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

1 reference

12 December 2020

Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy.

1 reference

12 December 2020

The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the radiation therapy oncology group

1 reference

12 December 2020

A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors

1 reference

12 December 2020

Clinical practice guideline on the optimal radiotherapeutic management of brain metastases

1 reference

12 December 2020

Response of leptomeningeal metastases from breast cancer to hormonal therapy

1 reference

12 December 2020

Neoplastic meningitis

1 reference

12 December 2020

10.1007/S00066-010-2100-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference